Eupraxia Pharmaceuticals Inc
TSX:EPRX
Eupraxia Pharmaceuticals Inc
Depreciation & Amortization
Eupraxia Pharmaceuticals Inc
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Eupraxia Pharmaceuticals Inc
TSX:EPRX
|
Depreciation & Amortization
-CA$168.8k
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Zymeworks Inc
NYSE:ZYME
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Depreciation & Amortization
-$2m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Spectral Medical Inc
TSX:EDT
|
Depreciation & Amortization
-CA$289k
|
CAGR 3-Years
2%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-2%
|
See Also
What is Eupraxia Pharmaceuticals Inc's Depreciation & Amortization?
Depreciation & Amortization
-168.8k
CAD
Based on the financial report for Dec 31, 2023, Eupraxia Pharmaceuticals Inc's Depreciation & Amortization amounts to -168.8k CAD.
What is Eupraxia Pharmaceuticals Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
-5%
Over the last year, the Depreciation & Amortization growth was 11%. The average annual Depreciation & Amortization growth rates for Eupraxia Pharmaceuticals Inc have been -12% over the past three years , -5% over the past five years .